University spin-off raises PLN 10.5 million for the development of a modern anti-cancer vaccine platform
VVAXICAN, a spin-off of the University of Gdańsk originating from the Intercollegiate Faculty of Biotechnology of the University of Gdańsk and the Medical University of Gdańsk (MWB UG i GUMed), a biotechnology company developing a modern platform for anti-cancer vaccines based on proprietary virus-like particle (eVLP) technology and providing advanced next-generation sequencing (NGS) services, has […]
